| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Frances K Heller last filed a Form 4 in October 2017, as Director at LRMR. Frances K Heller's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 47,961 shares of LRMR. Net of sales, the LRMR filings show accumulation of 40,000 shares.
Frances K Heller has 7 Form 4 filings on record from July 2015 to October 2017, all as Director at Larimar Therapeutics (LRMR), 2015–2017.
The 7 reported transactions were 4 open-market purchases and 3 option or other derivative awards.
Counted by filing, the open-market trades come to 4 purchases worth about $137K and no sales.
The largest open-market purchase was 10,000 shares of LRMR at an average $3.90 on October 13, 2017, about $39K.
Shares as reported in the last Form 4 for each company; the most recent is from October 2017. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 13, 2017 | LRMR Larimar Therapeutics, Inc. | Director | Buy | 10,000 | $3.90 | $38,988.00 | +26.3% | |
| Dec 19, 2016 | LRMR Larimar Therapeutics, Inc. | Director | Buy | 10,000 | $3.23 | $32,290.00 | +50.0% | |
| Nov 15, 2016 | LRMR Larimar Therapeutics, Inc. | Director | Buy | 10,000 | $3.54 | $35,434.00 | +100.0% | |
| Jul 22, 2016 | LRMR Larimar Therapeutics, Inc. | Director | Buy | 10,000 | $2.99 | $29,900.00 | New |